nach oben

Health Care Analysis

Erschienen in:

04.07.2016 | Original Article

Examining the Social Benefits Principle in Research with Human Participants

verfasst von: David B. Resnik

Erschienen in: Health Care Analysis | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The idea that research with human participants should benefit society has become firmly entrenched in various regulations, policies, and guidelines, but there has been little in-depth analysis of this ethical principle in the bioethics literature. In this paper, I distinguish between strong and weak versions and the social benefits principle and examine six arguments for it. I argue that while it is always ethically desirable for research with human subjects to offer important benefits to society (or the public), the reasonable expectation of substantial public benefit should be a necessary condition for regarding research as ethical only when (a) it imposes more than minimal risks on non-consenting subjects; or (b) it is supported by public resources.

The interpretation of “minimal risk” has been controversial but I will not explore that issue here [36, 44‐46].

It is worth noting that some versions of utilitarianism and Christian ethics may also imply strong duties to sacrifice our own well-being for the sake of others. For example, Singer [42] argues that our obligation to help others implies that we should be willing to bring our own well-being down to the level of those who are worse-off than we are. If there are people starving in the world, we should give them aid until our own well-being is not greater than theirs [42]. Others argue that Singer’s view is too demanding and moralistic. Our duties to help others are not as extensive as Singer supposes [15].

Beneficent actions are morally required when you have fiduciary relationships to other people. For example, parents have fiduciary obligations to benefit their children and doctors have fiduciary obligations to benefit their patients. The beneficence argument focuses on our obligations to help individuals we do not have fiduciary relationships with.

Annas, G. J., & Grodin, M. A. (Eds.). (1995). The Nazi doctors and the Nuremberg Code: Human rights in human experimentation. New York: Oxford University Press.

Centers for Disease Control and Prevention. (2016). About Zika virus disease. Retrieved from http://www.cdc.gov/zika/about/index.html.

Council for the Organizations of Medical Sciences (CIOMS). (2002). International ethical guidelines for biomedical research involving human subjects. Geneva: Council for the Organizations of Medical Sciences.

Department of Health and Human Services. (2009). Protection of human subjects. 45 CFR 46.

Emanuel, E. J. (2008). Benefits to host countries. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford handbook of clinical research ethics (pp. 719–728). New York: Oxford University Press.

Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283(20), 2701–2711.CrossRefPubMed

Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Diseases, 189(5), 930–937.CrossRefPubMed

Feinberg, J. (1986). Harm to self. New York: Oxford University Press.

Feinberg, J. (1987). Harm to others. New York: Oxford University Press.

10.

Frankena, W. F. (1988). Ethics (2nd ed.). Upper Saddle River: Pearson.

11.

Habets, M. G., van Delden, J. J., & Bredenoord, A. L. (2014). The social value of clinical research. BMC Medical Ethics, 5(15), 66.CrossRef

12.

Hawkins, J. S., & Emanuel, E. J. (Eds.). (2008). Exploitation and developing countries: The ethics of clinical research. Princeton: Princeton University Press.

13.

Iltis, A. (2007). Pediatric research posing a minor increase over minimal risk and no prospect of direct benefit: challenging 45 CFR 46.406. Accountability in Research, 14(1), 19–34.CrossRefPubMed

14.

Kant, I. (1964)[1785]. Groundwork of the metaphysics of morals (H.D, Paton, Trans.). New York: Harper and Rowe.

15.

Kekes, J. (2002). On the supposed obligation to relieve famine. Philosophy, 77(302), 503–517.

16.

Kitcher, P. (2001). Science, truth, and democracy. New York: Oxford University Press.CrossRef

17.

Kopelman, L. M. (2000). Children as research subjects: A dilemma. Journal of Medicine and Philosophy, 25(6), 745–764.CrossRefPubMed

18.

Levine, R. J. (1988). Ethics and regulation of clinical research (2nd ed.). New Haven: Yale University Press.

19.

London, A. J. (2003). Threats to the common good: Biological weapons and human subjects research. Hastings Center Report, 33(5), 17–25.CrossRefPubMed

20.

London, A. J. (2005). Does research ethics rest on a mistake? The common good, reasonable risk and social justice. American Journal of Bioethics, 5(1), 37–39.CrossRefPubMed

21.

London, A. J. (2012). A non-paternalistic model of research oversight: assessing the benefits of prospective review. Journal of Law, Medicine & Ethics, 40(4), 930–944.CrossRef

22.

London, A. J., Kimmelman, J., & Carlisle, B. (2012). Rethinking research ethics: The case of postmarketing trials. Science, 336(6081), 544–545.CrossRefPubMedPubMedCentral

23.

McCormick, R. A. (1976). Experimentation in children: Sharing sociality. Hastings Center Report, 6(6), 41–46.CrossRefPubMed

24.

Miller, F. G., & Wertheimer, A. (2007). Facing up to paternalism in research ethics. Hastings Center Report, 37(3), 24–34.CrossRefPubMed

25.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The belmont report: Ethical principles and guidelines for the protection of human subjects of research. Washington, DC: U.S. Department of Health, Education, and Welfare.

26.

Needleman, H. L., Reigart, J. R., Landrigan, P., Sass, J., & Bearer, C. (2005). Benefits and risks of pesticide testing on humans. Environmental Health Perspectives, 113(12), A804–A805.CrossRefPubMedPubMedCentral

27.

Nuremberg Code. (1949). Retrieved from: http://www.hhs.gov/ohrp/archive/nurcode.html.

28.

Nussbaum, M. C. (2013). Creating capabilities: The human development approach. Cambridge: Harvard University Press.

29.

Ramsey, P. (1976). A reply to Richard McCormick: The enforcement of morals: nontherapeutic research on children. Hastings Center Report, 6(4), 21–30.CrossRefPubMed

30.

Rawls, J. (1971). A theory of justice. Cambridge: Harvard University Press.

31.

Resnik, D. B. (2008). The social benefits of human subjects research. Journal of Clinical Research Best Practices, 4(11), 1–7.PubMedPubMedCentral

32.

Resnik, D. B. (2009). Playing politics with science. New York, NY: Oxford University Press.CrossRef

33.

Resnik, D. B. (2012). Limits on risks for health volunteers in biomedical research. Theoretical Medicine and Bioethics, 33(2), 137–149.CrossRefPubMedPubMedCentral

34.

Resnik, D. B., & Portier, C. (2005). Pesticide testing on human subjects: Weight benefits and risks. Environmental Health Perspectives, 113(7), 813–817.CrossRefPubMedPubMedCentral

35.

Rid, A., & Wendler, D. (2011). A framework for risk-benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal, 21(2), 141–179.CrossRefPubMed

36.

Ross, L. F. (2006). Children in medical research: Access versus protection. New York: Oxford University Press.CrossRef

37.

Samuelson, P., & Nordhaus, W. (2009). Economics (19th ed.). New York: McGraw-Hill.

38.

Sen, A. J. (1987). On ethics and economics. Oxford: Basil Blackwell.

39.

Shah, S. (2006). The body hunters: Testing new drugs on the world’s poorest patients. New York: New Press.

40.

Shamoo, A. E., & Resnik, D. B. (2015). Responsible conduct of research (3rd ed.). New York, NY: Oxford University Press.

41.

Shuster, E. (1997). Fifty years later: The significance of the Nuremberg Code. New England Journal of Medicine, 337(20), 1436–1440.CrossRefPubMed

42.

Singer, P. (1972). Famine, affluence, and morality. Philosophy and Public Affairs, 1(1), 229–243.

43.

Sox, H. C., & Rennie, D. (2008). Seeding trials: just say “no”. Annals of Internal Medicine, 149(4), 279–280.CrossRefPubMed

44.

Wendler, D. (2010). The ethics of pediatric research. New York: Oxford University Press.CrossRef

45.

Wendler, D. (2013). Do U.S. regulations allow more than minor increase over minimal risk pediatric research? Should they? IRB, 35(6), 1–8.PubMedPubMedCentral

46.

Wendler, D., & Varma, S. (2006). Minimal risk in pediatric research. Journal of Pediatrics, 149(6), 855–861.CrossRefPubMed

47.

Wertheimer, A. (1999). Exploitation. Princeton: Princeton University Press.

48.

Wertheimer, A. (2015). The social value requirement reconsidered. Bioethics, 29(5), 301–308.CrossRefPubMed

49.

World Medical Association. (2013). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: www.wma.net/en/30publications/10policies/b3/. Accessed 1 July 2016.

50.

Ziman, J. (2000). Real science. Cambridge: Cambridge University Press.CrossRef

Titel: Examining the Social Benefits Principle in Research with Human Participants
verfasst von: David B. Resnik
Publikationsdatum: 04.07.2016
Verlag: Springer US
Erschienen in: Health Care Analysis / Ausgabe 1/2018
Print ISSN: 1065-3058
Elektronische ISSN: 1573-3394
DOI: https://doi.org/10.1007/s10728-016-0326-2

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Health Without Care? Vulnerability, Medical Brain Drain, and Health Worker Responsibilities in Underserved Contexts

Why Health and Social Care Support for People with Long-Term Conditions Should be Oriented Towards Enabling Them to Live Well

How Much Care is Enough? Carer’s Guilt and Bergsonian Time

Individualised Claims of Conscience, Clinical Judgement and Best Interests

If You’re a Rawlsian, How Come You’re So Close to Utilitarianism and Intuitionism? A Critique of Daniels’s Accountability for Reasonableness

Beyond Fair Benefits: Reconsidering Exploitation Arguments Against Organ Markets